PD Dr. Dieter Brockmann (phone +49 731/50-33630, e-mail:
Petra Staudacher (phone +49 731/50-33634, e-mail:

Boehringer Ingelheim Ulm University BioCenter (BIU)

On October 19, 2011 Prof. Dr. Gerd Schnorrenberg, Senior Vice President of Boehringer Research Germany and Prof. Dr. Karl Joachim Ebeling, President of the University of Ulm, signed the co-operation agreement of the "Public-Private-Partnership-Research Association BIU" in the presence of Theresia Bauer, Minister of Research of the State of Baden-Wuerttemberg, and Prof. Dr. Dr. Andreas Barner, Speaker of the Boehringer Ingelheim management.

The research will focus neurodegenerative, cardio metabolic as well as lung diseases. The goals of the newly founded research association are the identification and characterization of new biomarkers, the analysis of misregulated signaling pathways as well as establishing new innovative preclinical and clinical concepts in translational research. The BioCenter is founded according to the structures and criteria of the well-established collaborative research centers of the German Research Foundation (DFG). Boehringer Ingelheim, the State of Baden-Wuerttemberg and the Medical Faculty of the University of Ulm will support the program with 4.5 Million Euros for 8 years with an evaluation after the first three years.

An external evaluation led to the funding of the following projects:

Cardiometabolic Diseases
Lung Diseases
Neurodegenerative Diseases

After signing the contract: (from left to right) Prof. Klaus-Michael Debatin (Vice President of Ulm University), Prof. Andreas Barner (Speaker of the Boehringer Ingelheim management), Theresia Bauer (Minister of Research of the State of Baden-Wuerttemberg), Prof. Dr. Gerd Schnorrenberg (Senior Vice President of Boehringer Research Germany), Prof. Karl-Joachim Ebeling (President of Ulm University). Photo: University Medical Center Ulm